PB2142: SERUM OSTEOCALCIN AS A PREDICTOR FOR THE RISK OF DENOSUMAB AND BISPHOSPHONATE INDUCED HYPOCALCEMIA IN MYELOMA PATIENTS WITH HYPERCALCEMIA

• Yuehua Ding,
• Minqiu Lu,
• Bin Chu,
• Lei Shi,
• Shan Gao,
• Qiuqing Xiang,
• Lijuan Fang,
• Yutong Wang,
• XI Liu,
• Xin Zhao,
• Mengzhen Wang,
• Yuan Chen,
• Sun Kai,
• LI Bao

Affiliations

Yuehua Ding

1 Beijing Jishuitan Hospital, Department of Hematology, China

Minqiu Lu

1 Beijing Jishuitan Hospital, Department of Hematology, China

Bin Chu

1 Beijing Jishuitan Hospital, Department of Hematology, China

Lei Shi

1 Beijing Jishuitan Hospital, Department of Hematology, China

Shan Gao

1 Beijing Jishuitan Hospital, Department of Hematology, China

Qiuqing Xiang

2 Beijing Jishuitan Hospital, Department of Hematology, China

Lijuan Fang

3 Beijing Jishuitan Hospital, Department of Hematology, China

Yutong Wang

3 Beijing Jishuitan Hospital, Department of Hematology, China

XI Liu

3 Beijing Jishuitan Hospital, Department of Hematology, China

Xin Zhao

3 Beijing Jishuitan Hospital, Department of Hematology, China

Mengzhen Wang

3 Beijing Jishuitan Hospital, Department of Hematology, China

Yuan Chen

4 Beijing Jishuitan Hospital, Department of Hematology, China

Sun Kai

1 Beijing Jishuitan Hospital, Department of Hematology, China

LI Bao

2 Beijing Jishuitan Hospital, Department of Hematology, China